Optimizing HIV Medicines for AIDS-Related Lymphoma
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy, Infections clinical trials.
This trial helps doctors find the best way to combine HIV medicines (antiretroviral therapy) with lymphoma treatment for people who have both HIV and AIDS-related lymphoma. The goal is to improve your overall care and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed HIV infection.
- You have been diagnosed with AIDS-related lymphoma (a lymphoma linked to HIV).
- You are currently receiving treatment for your lymphoma.
- You are willing to take HIV medications and cancer treatment as directed by your doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a registry (a protected health record database) of adults with lymphoma who also have HIV. The goal is to better understand lymphoma in people with HIV and how they’re diagnosed and followed over time.
This study tests if a two-drug HIV regimen (darunavir/cobicistat plus lamivudine) works as well as a standard three-drug regimen in men whose HIV is already well-controlled. If effective, this could mean taking fewer medications.
This trial tests a new treatment combination for people with advanced Hodgkin lymphoma who also have HIV. The goal is to see if this approach is safe and works better than current options.
This trial tests a new mRNA vaccine that targets the Epstein-Barr virus (EBV) in people with HIV-related lymphoma. The goal is to see if the vaccine can help the immune system fight the cancer, especially for those whose lymphoma has not fully responded to standard treatments.
This study follows adults with well-controlled HIV who are planning to switch to a long-acting HIV medicine given as injections. It may help researchers understand how this approach works for people already stable on current treatment.
This trial tests a new drug called glofitamab combined with standard chemoimmunotherapy (called R-CHOP) for people with HIV-related large B-cell lymphoma that has not been treated before. The goal is to see if adding this drug improves outcomes and is safe.
Hear when a new AIDS-related Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.